Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D-2 Receptor Subtype 1
文献类型:期刊论文
作者 | Kong, Deping4,5; Shen, Yujun4; Yu, Ying4,5; Liu, Guizhu5; Zuo, Shengkai5; Tao, Bo5; Li, Juanjuan6; Lu, Ankang7; Ji, Yong8; Lazarus, Michael1 |
刊名 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
![]() |
出版日期 | 2017 |
卷号 | 360期号:3页码:435-444 |
关键词 | Ebola virus pathogenic mechanism shortest path human protein identification betweenness GO enrichment |
ISSN号 | 0022-3565 |
DOI | 10.1124/jpet.116.238261 |
文献子类 | Article |
英文摘要 | Niacin is a well established drug used to lower cholesterol and prevent cardiovascular disease events. However, niacin also causes cutaneous flushing side effects due to release of the proresolution mediator prostaglandin D-2 (PGD(2)). Recent randomized clinical trials have demonstrated that addition of niacin with laropiprant [a PGD2 receptor subtype 1 (DP1) blocker] to statin-based therapies does not significantly decrease the risk of cardiovascular disease events, but increases the risk of serious adverse events. Here, we tested whether, and how, niacin beneficial effects on myocardial ischemia require the activation of the PGD(2)/DP1 axis. Myocardial infarction (MI) was reproduced by ligation of the left anterior descending branch of the coronary artery in mice. We found that niacin increased PGD(2) release in macrophages and shifted macrophages to M2 polarization both in vitro and in vivo by activation of DP1 and accelerated inflammation resolution in zymosan-induced peritonitis in mice. Moreover, niacin treatment facilitated wound healing and improved cardiac function after MI through DP1-mediated M2 bias and timely resolution of inflammation in infarcted hearts. In addition, we found that niacin intake also stimulated M2 polarization of peripheral monocytes in humans. Collectively, niacin promoted cardiac functional recovery after ischemic myocardial infarction through DP1-mediated M2 polarization and timely resolution of inflammation in hearts. These results indicated that DP1 inhibition may attenuate the cardiovascular benefits of niacin. |
学科主题 | Pharmacology & Pharmacy |
WOS关键词 | NICOTINIC-ACID ; MOLECULAR-IDENTIFICATION ; ALLERGIC INFLAMMATION ; D SYNTHASE ; IN-VITRO ; PGD(2) ; CELLS ; MICE ; BIOSYNTHESIS ; HUMANS |
语种 | 英语 |
WOS记录号 | WOS:000394539900007 |
出版者 | AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS |
版本 | 出版稿 |
源URL | [http://202.127.25.144/handle/331004/1228] ![]() |
专题 | 中国科学院上海生命科学研究院营养科学研究所 |
作者单位 | 1.Univ Tsukuba, Int Inst Integrat, Sleep Med, Tsukuba, Ibaraki, Japan; 2.Vanderbilt Univ, Med Ctr, Dept Vet Affairs, Tennessee Valley Hlth Author, Nashville, TN USA; 3.Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA, 4.Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin 300070, Peoples R China; 5.Univ Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab food safety Res, Shanghai, Peoples R China; 6.Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Gastroenterol, Shanghai, Peoples R China; 7.Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Cardiol, Shanghai, Peoples R China; 8.Nanjing Med Univ, Atherosclerosis Res Ctr, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China; |
推荐引用方式 GB/T 7714 | Kong, Deping,Shen, Yujun,Yu, Ying,et al. Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D-2 Receptor Subtype 1[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,2017,360(3):435-444. |
APA | Kong, Deping.,Shen, Yujun.,Yu, Ying.,Liu, Guizhu.,Zuo, Shengkai.,...&,.(2017).Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D-2 Receptor Subtype 1.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,360(3),435-444. |
MLA | Kong, Deping,et al."Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D-2 Receptor Subtype 1".JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 360.3(2017):435-444. |
入库方式: OAI收割
来源:上海营养与健康研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。